C S Farah
Overview
Explore the profile of C S Farah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
1659
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farah C
Aust Dent J
. 2021 Feb;
66(3):340-345.
PMID: 33547810
Secukinumab (Cosentyx®) is an IL-17A inhibitor which is used for the management of psoriasis, active psoriatic arthritis or ankylosing spondylitis. Oral adverse events of secukinumab therapy are not widely appreciated....
2.
Tonga K, King G, Farah C, Thamrin C, Tang F, Santos J, et al.
Respir Res
. 2018 Sep;
19(1):176.
PMID: 30223904
There is limited evidence linking airway inflammation and lung function impairment in older non-smoking asthmatics with fixed airflow obstruction (FAO), which can develop despite treatment with inhaled corticosteroids (ICS). We...
3.
Farah C
Oral Dis
. 2018 Feb;
24(1-2):89-97.
PMID: 29480612
Purpose: Overall local recurrence of oral squamous cell carcinoma (OSCC) is estimated at 20%. Incomplete primary tumour excision contributes to localised postsurgical recurrence of OSCC. The purpose of this study...
4.
Farah C, Kordbacheh F, John K, Bennett N, Fox S
Oral Dis
. 2017 Dec;
24(5):732-740.
PMID: 29243374
Objective: To define molecular differences between autofluorescence and white light defined excision margins in oral potentially malignant disorders (OPMD) using transcriptome expression profiles. Materials And Methods: Excisional biopsy specimens were...
5.
Dost F, Do L, Farah C
Aust Dent J
. 2016 Jan;
61(4):432-439.
PMID: 26780197
Background: Patient awareness of risk factors associated with cancer has been shown to increase patient presentation for screening and early detection. This study aimed to identify the level of awareness...
6.
Kordbacheh F, Bhatia N, Farah C
Oral Dis
. 2016 Jan;
22(4):285-96.
PMID: 26749103
Objectives: We aimed to elucidate the molecular pathways associated with fluorescence properties of oral potentially malignant disorders (OPMD) visualised under direct tissue autofluorescence (VELscope(™)). Materials And Methods: Forty-two oral mucosal...
7.
Vu A, Farah C
Oral Dis
. 2015 Dec;
22(5):383-90.
PMID: 26713751
Narrow Band Imaging (NBI) is an endoscopic optical imaging enhancement technology that improves the contrast of mucosal surface texture, and enhances visualisation of mucosal and submucosal vasculature. White light is...
8.
Lalla Y, Matias M, Farah C
Aust Dent J
. 2015 May;
60(2):216-24.
PMID: 25990387
Background: The aim of this study was to document the oral mucosal burden in an urban Indigenous community and to evaluate the efficacy of an adjunctive optical device (Identafi(™) )...
9.
Allen K, Farah C
Aust Dent J
. 2015 Feb;
60(1):52-8.
PMID: 25721278
Background: Oral squamous cell carcinomas and potentially malignant oral disorders can be detected early by visually inspecting the oral soft tissues. This study aimed to determine Australian dentists' opinions and...
10.
Diagnostic accuracy of Narrow Band Imaging for the detection of oral potentially malignant disorders
Vu A, Matias M, Farah C
Oral Dis
. 2015 Jan;
21(4):519-29.
PMID: 25619340
Objective: To determine the clinical diagnostic accuracy of Narrow Band Imaging(™) for the detection of oral potentially malignant disorders in a prospective series of patients. Materials And Methods: New and...